The transatlantic healthcare landscape presents a complex tapestry of diverse approaches to cancer care. While both the United States and Europe boast remarkable advancements in oncology, significant discrepancies exist in their respective frameworks. This article delves into these gaps, exploring the factors shaping them and highlighting potential